Brief: Neurocrine Biosciences Appoints Dr. Sanjay Keswani As Chief Medical Officer
04/04/2025 13:03
April 4 (Reuters) - Neurocrine Biosciences Inc NBIX.O: NEUROCRINE BIOSCIENCES APPOINTS DR. SANJAY KESWANI AS CHIEF MEDICAL OFFICER Source text: ID:nPn5W8yx4a Further company coverage: NBIX.O (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Neurocrine Biosciences
See all newsBrief: Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating Nbi-'567 In Adults With Alzheimer's Disease
Nxera Pharma's Partner Neurocrine Biosciences Receives Ind Acceptance From FDA For Phase 2 Study Of Nbi-1117567 For Alzheimer's Cognition
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Prader-Willi groups cite deaths tied to Neurocrine's genetic disorder drug, shares fall